Alison Joan Lunsford MD
Assistant Professor, Pediatrics, Prisma health
Join to view full profile
9 Richland Medical Park DrSte 1500Columbia, SC 29203
Phone+1 803-434-7990
Fax+1 806-354-5689
Dr. Lunsford is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Alison Lunsford is a Pediatric Endocrinologist based in Columbia, SC, currently serving as an Assistant Professor at Prisma Health - Midlands. She completed her fellowship in Pediatric Endocrinology at the University of Alabama Medical Center and her residency in Pediatrics at Prisma Health/University of South Carolina SOM Columbia. Her research work includes publications on topics such as Type 1 Diabetes, diabetic ketoacidosis, and reproductive function in cancer survivors. She has also been involved in a clinical trial investigating GABA supplementation in children's Type 1 Diabetes progression.
Education & Training
University of Alabama Hospital (Birmingham)Fellowship, Pediatric Endocrinology, 2010 - 2013
Prisma Health/University of South Carolina SOM Columbia (Columbia)Residency, Pediatrics, 2007 - 2010
University of Oklahoma College of MedicineClass of 2007
Certifications & Licensure
SC State Medical License 2023 - 2027
TX State Medical License 2013 - 2025
AL State Medical License 2010 - 2013
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
Publications & Presentations
PubMed
- 12 citationsProinsulin to C-Peptide Ratio in the First Year After Diagnosis of Type 1 Diabetes.Jurhee Freese, Rawan Al-Rawi, Heather M. Choat, Alexandra Martin, Alison J. Lunsford
The Journal of Clinical Endocrinology and Metabolism. 2021-10-21 - 10 citationsEtiologies, trends, and predictors of 30-day pediatric readmissions after hospitalizations for diabetic ketoacidosis in the United States.Parth Bhatt, Mihir Dave, Jason K. Amponsah, Apurva Jain, Priyank J Yagnik
Pediatric Diabetes. 2020-09-01 - 4 citationsA 26-week, randomized trial of insulin detemir versus NPH insulin in children and adolescents with type 2 diabetes (iDEAt2).Mark D. Wheeler, Margarita Barrientos-Perez, Fu Sung Lo, Bo Liang, Alison Lunsford
European Journal of Pediatrics. 2018-07-16
Press Mentions
- Lumos Pharma Reports First Quarter 2023 Financial Results, Provides Clinical UpdatesMay 3rd, 2023
- Additional Data on Lumos OraGrowtH Trials Presented at International Meeting of Pediatric EndocrinologyMarch 5th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: